SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma

PRISM MediaWire - News and Media Service

Thomas’s Podcast

SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma

1×

0:00

-2:41

SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma

Jun 11, 2024

Discussion about this podcast

Thomas’s Podcast

Podcast Episodes about Micro Cap News and Updates

Listen on

Substack App

Spotify

RSS Feed

Appears in episode

Thomas Wolff

Recent Episodes

Catch the Latest Buzz: Weekly News Release Highlights

Jul 19 • Thomas Wolff

PRISM MediaWire: Catch the Latest Buzz: Weekly News Release Highlights

Jul 12 • Thomas Wolff

Rodedawg (OTC: RWGI) Launches TikTok Shop to Expand into Global E-Commerce Market

Jun 12 • Thomas Wolff

SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia

Jun 11 • Thomas Wolff

Rodedawg Expands into Dispensary Acquisitions and Signs Letter of Intent for Dispensary License

Jun 6 • Thomas Wolff

Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers

Jun 5 • Thomas Wolff

Rodedawg Announces Successful Launch of Nutrient CBD Product Line

Jun 4 • Thomas Wolff

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts